• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌症放疗后下颌骨放射性骨坏死:危险因素和剂量-体积相关性。

Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.

机构信息

Department of Oncology, Odense University Hospital , Odense , Denmark.

Institute of Clinical Research, University of Southern Denmark , Odense , Denmark.

出版信息

Acta Oncol. 2019 Oct;58(10):1373-1377. doi: 10.1080/0284186X.2019.1643037. Epub 2019 Jul 31.

DOI:10.1080/0284186X.2019.1643037
PMID:31364903
Abstract

The project aimed at determining the incidence of mandibular osteoradionecrosis (ORN) after radiotherapy, possible risk factors, and mandibular dose-volume effects in a large cohort of head and neck cancer patients (HNC). The cohort consisted of 1224 HNC patients treated with 66-68 Gy in 2007-2015 predominantly with IMRT. ORN cases were defined from clinical observations at follow-up and through hospital code diagnostics after oral-maxillofacial surgery and cross-checked with the national Danish Head and Neck Cancer database. In a nested case-control study, patients with ORN cases were matched with two controls (1:2) and pre-RT dental procedures including surgery to the mandible were documented. Multivariable Cox regression analysis was applied using demographic and treatment variables including dental procedures, smoking and tumor characteristics, and combined with dosimetric data. Mean mandibular dose () was pre-selected for the multivariable model. ORN was recorded in 56 cases (4.6%) with a median time to event of 10.9 months (range 1.8-89.7) after RT, 90% occurred within 37.4 months. Median follow-up time was 22 months (0.3-95). Average was significantly higher in the ORN event cohort and significant dose-volume differences were observed for population mean DVH doses between 30 Gy and 60 Gy. In univariable analysis, smoking (HR = 1.69; CI 1.14-2.5), pre-RT surgery/tooth extraction (HR = 2.76; 1.48-5.14), and several dosimetric parameters including (HR = 1.05, 1.02-1.08) were all significantly associated with ORN. and surgery/tooth extraction remained significant predictors of ORN in multivariable analysis, HR = 1.04 (CI 1.01-1.07) and HR = 2.09 (CI 1.1-3.98), respectively, while smoking only retained its significance in an interaction analysis with pre-RT dental procedures. The onset of ORN of the mandible was early (median 10.8 months) and the incidence low (4.6%) after IMRT in HNC cancer patients. Surgery to the mandible and pre-RT tooth extraction, tobacco smoking, and treatment dose were associated with the development of ORN.

摘要

该项目旨在确定接受放疗后下颌骨放射性骨坏死(ORN)的发生率、可能的危险因素以及头颈癌(HNC)患者中下颌骨剂量-体积效应。该队列由 1224 名 HNC 患者组成,他们在 2007 年至 2015 年间接受了 66-68Gy 的治疗,主要采用调强放疗(IMRT)。ORN 病例是通过随访时的临床观察以及口腔颌面手术后医院代码诊断确定的,并与丹麦全国头颈部癌症数据库进行了交叉核对。在一项嵌套病例对照研究中,将 ORN 病例与两名对照(1:2)匹配,并记录放射治疗前的牙科手术程序,包括下颌手术。使用多变量 Cox 回归分析方法,结合人口统计学和治疗变量(包括牙科手术、吸烟和肿瘤特征)以及剂量学数据。选择平均下颌剂量()作为多变量模型的预筛选。在放疗后 10.9 个月(范围 1.8-89.7)时记录到 56 例(4.6%)ORN,中位事件时间为 90%发生在 37.4 个月内。中位随访时间为 22 个月(0.3-95)。在 ORN 事件队列中,平均下颌剂量显著较高,人群平均剂量体积直方图(DVH)剂量在 30Gy 至 60Gy 之间存在显著的剂量-体积差异。单变量分析显示,吸烟(HR=1.69;95%CI:1.14-2.5)、放疗前手术/拔牙(HR=2.76;95%CI:1.48-5.14)以及包括(HR=1.05,1.02-1.08)等几个剂量学参数均与 ORN 显著相关。多变量分析中,吸烟和手术/拔牙仍然是 ORN 的显著预测因子,HR=1.04(95%CI:1.01-1.07)和 HR=2.09(95%CI:1.1-3.98),而吸烟仅在与放疗前牙科手术程序的交互分析中保留其意义。HNC 癌症患者接受 IMRT 后,下颌骨 ORN 的发病时间较早(中位时间 10.8 个月),发生率较低(4.6%)。下颌骨手术和放疗前拔牙、吸烟以及治疗剂量与 ORN 的发生有关。

相似文献

1
Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.头颈部癌症放疗后下颌骨放射性骨坏死:危险因素和剂量-体积相关性。
Acta Oncol. 2019 Oct;58(10):1373-1377. doi: 10.1080/0284186X.2019.1643037. Epub 2019 Jul 31.
2
Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.调强放疗治疗口咽癌患者的下颌骨放射性骨坏死。
Cancer. 2017 Oct 1;123(19):3691-3700. doi: 10.1002/cncr.30803. Epub 2017 Jun 13.
3
Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions.头颈部癌调强放疗后下颌骨放射性骨坏死的缺失:牙科护理和改善剂量分布的可能作用
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):396-402. doi: 10.1016/j.ijrobp.2006.11.059. Epub 2007 Feb 22.
4
Risk factors associated with the development of osteoradionecrosis (ORN) in Head and Neck cancer patients in Ireland: A 10-year retrospective review.爱尔兰头颈部癌症患者放射性骨坏死(ORN)发展的相关风险因素:一项 10 年回顾性研究。
Radiother Oncol. 2024 Jul;196:110286. doi: 10.1016/j.radonc.2024.110286. Epub 2024 Apr 17.
5
Prognostic Factors of Mandibular Osteoradionecrosis Including Accurate Colocalization of Avulsions and Dosimetric Dental Mapping Software, a Case-control Study.下颌骨放射性骨坏死的预后因素,包括精确的撕脱定位和剂量学牙映射软件:一项病例对照研究。
Int J Radiat Oncol Biol Phys. 2024 Nov 1;120(3):783-795. doi: 10.1016/j.ijrobp.2024.04.019. Epub 2024 Apr 27.
6
Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.接受调强放疗的口咽癌患者下颌骨放射性骨坏死的剂量-体积相关性:病例匹配比较结果
Radiother Oncol. 2017 Aug;124(2):232-239. doi: 10.1016/j.radonc.2017.06.026. Epub 2017 Jul 18.
7
Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者颌骨放射性骨坏死的危险因素。
Radiat Oncol. 2021 Jan 5;16(1):1. doi: 10.1186/s13014-020-01701-5.
8
Normal Tissue Complication Probability (NTCP) Prediction Model for Osteoradionecrosis of the Mandible in Patients With Head and Neck Cancer After Radiation Therapy: Large-Scale Observational Cohort.头颈部癌症放疗后下颌骨放射性骨坏死的正常组织并发症概率(NTCP)预测模型:大规模观察性队列。
Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):549-558. doi: 10.1016/j.ijrobp.2021.04.042. Epub 2021 Jun 10.
9
Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).下颌骨放射性骨坏死:调强放射治疗(IMRT)后风险状况降至最低
Strahlenther Onkol. 2006 May;182(5):283-8. doi: 10.1007/s00066-006-1477-0.
10
Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers.口腔和口咽癌患者下颌骨放射性骨坏死的发生率及危险因素。
Oral Oncol. 2017 Sep;72:98-103. doi: 10.1016/j.oraloncology.2017.07.014. Epub 2017 Jul 16.

引用本文的文献

1
Post head and neck cancer radiation therapy dynamic contrast enhanced magnetic resonance imaging association with high mandibular radiation dose.头颈部癌放疗后动态对比增强磁共振成像与高下颌骨辐射剂量的关联
medRxiv. 2025 Jul 25:2025.07.25.25332216. doi: 10.1101/2025.07.25.25332216.
2
Successful surgical management of a patient with osteoradionecrosis of the jaw with RET fusion-positive advanced thyroid cancer: A case report.放射性颌骨坏死合并RET融合阳性晚期甲状腺癌患者的成功手术治疗:病例报告
Exp Ther Med. 2025 May 29;30(2):148. doi: 10.3892/etm.2025.12898. eCollection 2025 Aug.
3
Effectiveness of advanced platelet-rich fibrin on post-exodontia socket healing in patients who had undergone head and neck radiation.
富含血小板的高级纤维蛋白对接受头颈部放疗患者拔牙后牙槽窝愈合的有效性。
Support Care Cancer. 2025 Apr 21;33(5):397. doi: 10.1007/s00520-025-09428-3.
4
Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohorts.使用右删失多机构观察性队列进行骨放射性坏死风险分层时间的外部验证数字决策支持工具。
Radiother Oncol. 2025 Jun;207:110890. doi: 10.1016/j.radonc.2025.110890. Epub 2025 Apr 11.
5
Critical review of patient outcome study in head and neck cancer radiotherapy.头颈部癌放疗患者结局研究的批判性综述
ArXiv. 2025 Mar 19:arXiv:2503.15691v1.
6
Occurrence of Jaw Osteonecrosis and Frequency of Prophylactic Tooth Extractions Prior to Head and Neck Radiotherapy: A Retrospective Study of 497 Irradiated Patients.头颈部放疗前颌骨骨坏死的发生率及预防性拔牙频率:对497例接受放疗患者的回顾性研究
J Clin Med. 2025 Feb 28;14(5):1661. doi: 10.3390/jcm14051661.
7
The relevance of dental management prior to radiation therapy with severe oral mucositis in head and neck cancer patients.头颈部癌症患者在放疗前进行牙齿管理与严重口腔黏膜炎的相关性。
J Dent Sci. 2025 Jan;20(1):522-528. doi: 10.1016/j.jds.2024.04.030. Epub 2024 May 6.
8
Diagnostic and Therapeutic Approaches to Jaw Osteoradionecrosis.颌骨放射性骨坏死的诊断与治疗方法
Diagnostics (Basel). 2024 Nov 27;14(23):2676. doi: 10.3390/diagnostics14232676.
9
Proactive Customized Protocol for Oral Management in Head and Neck Cancer Patients Planned for Radiotherapy.针对计划接受放疗的头颈癌患者的口腔管理主动定制方案。
J Maxillofac Oral Surg. 2024 Dec;23(6):1366-1370. doi: 10.1007/s12663-021-01511-6. Epub 2021 Jan 21.
10
External validation of a multimodality deep-learning normal tissue complication probability model for mandibular osteoradionecrosis trained on 3D radiation distribution maps and clinical variables.基于3D放射分布图和临床变量训练的下颌骨放射性骨坏死多模态深度学习正常组织并发症概率模型的外部验证
Phys Imaging Radiat Oncol. 2024 Nov 2;32:100668. doi: 10.1016/j.phro.2024.100668. eCollection 2024 Oct.